Page last updated: 2024-12-06
trefentanil
Description
Research Excerpts
Clinical Trials
Roles
Classes
Pathways
Study Profile
Bioassays
Related Drugs
Related Conditions
Protein Interactions
Research Growth
Description
trefentanil: RN refers to hydrochloride; a short-acting analgesic [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
Cross-References
ID Source | ID |
---|---|
PubMed CID | 60728 |
CHEMBL ID | 84617 |
SCHEMBL ID | 397177 |
MeSH ID | M0215069 |
Synonyms (19)
Synonym |
---|
trefentanyl |
CHEMBL84617 |
a-3665 , |
trefentanil |
n-[1-[2-(4-ethyl-5-oxotetrazol-1-yl)ethyl]-4-phenylpiperidin-4-yl]-n-(2-fluorophenyl)propanamide |
L001379 |
unii-36qm58lvgu |
120656-74-8 |
36qm58lvgu , |
trefentanil [inn] |
trefentanil [who-dd] |
n-(1-(2-(4-ethyl-4,5-dihydro-5-oxo-1h-tetrazol-1-yl)ethyl)-4-phenyl-4-piperidinyl)-n-(2-fluorophenyl)propanamide |
trefentanil [mart.] |
propanamide, n-(1-(2-(4-ethyl-4,5-dihydro-5-oxo-1h-tetrazol-1-yl)ethyl)-4-phenyl-4-piperidinyl)-n-(2-fluorophenyl)- |
a-3665 free base |
SCHEMBL397177 |
DTXSID80152955 |
DB09181 |
Q7837766 |
Research Excerpts
Dosage Studied
We determined the possible benefits of a new opioid, trefentanil, relative to fentanyl and alfent anil using high-resolution pharmacokinetic-pharmacodynamic modeling and computer simulations of clinical dosing scenarios. Finally, we used computer simulations to predict offset of opioid effects of trefenil, fentanyl, and alFENTanil when given in different dosing schemes.
Excerpt | Relevance | Reference |
---|---|---|
"We determined the possible benefits of a new opioid, trefentanil, relative to fentanyl and alfentanil using high-resolution pharmacokinetic-pharmacodynamic modeling and computer simulations of clinical dosing scenarios." | ( Pharmacokinetic-pharmacodynamic modeling in drug development: application to the investigational opioid trefentanil. Dyck, JB; Lemmens, HJ; Shafer, SL; Stanski, DR, 1994) | 0.29 |
" Finally, we used computer simulations to predict offset of opioid effects of trefentanil, fentanyl, and alfentanil when given in different dosing schemes." | ( Pharmacokinetic-pharmacodynamic modeling in drug development: application to the investigational opioid trefentanil. Dyck, JB; Lemmens, HJ; Shafer, SL; Stanski, DR, 1994) | 0.29 |
"We suggest that high-resolution pharmacokinetic-pharmacodynamic studies and computer simulations of clinical dosing scenarios may have significant usefulness in appreciating differences between new and established drugs in early phase I studies." | ( Pharmacokinetic-pharmacodynamic modeling in drug development: application to the investigational opioid trefentanil. Dyck, JB; Lemmens, HJ; Shafer, SL; Stanski, DR, 1994) | 0.29 |
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
Bioassays (4)
Assay ID | Title | Year | Journal | Article |
---|---|---|---|---|
AID114189 | Analgesic activity in nonfasted male mice at 55 degree C using Hot plate assay | 1989 | Journal of medicinal chemistry, Dec, Volume: 32, Issue:12 | 4-Phenyl- and 4-heteroaryl-4-anilidopiperidines. A novel class of analgesic and anesthetic agents. |
AID178398 | Effective dose for its analgesic activity in male Sprague-Dawley rats using rat hot plate assay | 1989 | Journal of medicinal chemistry, Dec, Volume: 32, Issue:12 | 4-Phenyl- and 4-heteroaryl-4-anilidopiperidines. A novel class of analgesic and anesthetic agents. |
AID189328 | Analgesic activity was determined by observing the recovery of motor coordination in rats | 1989 | Journal of medicinal chemistry, Dec, Volume: 32, Issue:12 | 4-Phenyl- and 4-heteroaryl-4-anilidopiperidines. A novel class of analgesic and anesthetic agents. |
AID178021 | Effective dose for analgesic activity in male Sprague-Dawley rats using tail flick method | 1989 | Journal of medicinal chemistry, Dec, Volume: 32, Issue:12 | 4-Phenyl- and 4-heteroaryl-4-anilidopiperidines. A novel class of analgesic and anesthetic agents. |
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Research
Studies (5)
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 1 (20.00) | 18.7374 |
1990's | 3 (60.00) | 18.2507 |
2000's | 1 (20.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Study Types
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 2 (40.00%) | 5.53% |
Reviews | 1 (20.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 2 (40.00%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |